Drug recall · October 18, 2017
Mobic (meloxicam) tablets recall
Why: Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
- Lots / codes
Lot 754037
- Quantity
- 128 bottles
- Company
- Boehringer Ingelheim Pharmaceuticals, Inc., Danbury, CT
- Distribution
- CO, OH
- Initiated
- September 22, 2017 · Voluntary: Firm initiated
- Classified
- October 6, 2017
- Reported
- October 18, 2017
- Ended
- April 18, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meloxicam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.